Statistics for A Bayesian Adaptive Phase I/II Clinical Trial Design with Late-onset Competing Risk Outcomes
Total visits
| views | |
|---|---|
| A Bayesian Adaptive Phase I/II Clinical Trial Design with Late-onset Competing Risk Outcomes | 90 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Zhang2020Bayesian-AAM.pdf | 186 |
| java.util.UUID:a899dd30-531c-4540-9198-a25f380eed9d | 113 |
| java.util.UUID:e0358310-d3ba-4515-a9ab-8506b367b2aa | 48 |
| java.util.UUID:2ac0a2bf-d447-4d8d-b579-fceb675e6162 | 34 |
| CR.R | 25 |
| Readme.txt | 25 |
| Zhang_supp.pdf | 22 |
| java.util.UUID:dd0f0fdf-2af7-4996-b412-164edacfca99 | 18 |
| java.util.UUID:d4522852-9886-49de-81c0-a5b2f664bdd8 | 14 |
| java.util.UUID:bdcddc4e-b05e-48a1-ac29-ed88fa28f457 | 12 |
Top country views
| views | |
|---|---|
| United States | 70 |
| China | 1 |
| Italy | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 45 |
| Fairfield | 6 |
| Houston | 4 |
| Ann Arbor | 2 |
| Cambridge | 2 |
| Beijing | 1 |
| Franklin | 1 |
| Lake Mary | 1 |
| Pomona | 1 |
| Rome | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Washington | 1 |